Sonesitatug Biosimilar - Research Grade

Human

CLDN18.2

>1mg/ml

Human IgG1 -kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P56856

Blue Ice

Claudin-18.2 (CLDN18.2) is a tight-junction protein selectively exposed on certain gastrointestinal tumors, making it an attractive targeting antigen in oncology research. This research-grade, non-therapeutic biosimilar analog of sonesitatug is a recombinant human IgG1 antibody directed against CLDN18.2, supplied for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo studies and produced in scalable milligram to gram quantities for high-throughput and bulk laboratories. The reagent supports antigen-binding and internalization assays, in vitro tumor-cell screening, control work, ADCC studies, and preclinical targeted-therapy and ADC development models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.